{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T06:50:40Z","timestamp":1773730240960,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003705","name":"Korea Institute of Toxicology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003705","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.biomaterials.2020.120599","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T17:13:56Z","timestamp":1607620436000},"page":"120599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Quantification of non-alcoholic fatty liver disease progression in 3D liver microtissues using impedance spectroscopy"],"prefix":"10.1016","volume":"268","author":[{"given":"Jaehwan","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Ho","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seokjoo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-Young","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungbo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Hwa","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biomaterials.2020.120599_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biomaterials.2020.120599_bib2","doi-asserted-by":"crossref","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","article-title":"Nonalcoholic fatty liver disease","volume":"1","author":"Brunt","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120599_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/17425255.2017.1246534","article-title":"Drug-induced steatohepatitis","volume":"13","author":"Dash","year":"2017","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.biomaterials.2020.120599_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.21037\/tgh.2019.03.04","article-title":"Liver-related mortality in the United States: hepatitis C declines, non-alcoholic fatty liver and alcohol rise","volume":"4","author":"Lee","year":"2019","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.biomaterials.2020.120599_bib5","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nrgastro.2013.175","article-title":"Noninvasive evaluation of NAFLD","volume":"10","author":"Castera","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120599_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH - current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1 Suppl","key":"10.1016\/j.biomaterials.2020.120599_bib7","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jhep.2015.02.041","article-title":"Current efforts and trends in the treatment of NASH","volume":"62","author":"Ratziu","year":"2015","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.biomaterials.2020.120599_bib8","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120599_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrgastro.2010.191","article-title":"Animal models of nonalcoholic fatty liver disease","volume":"8","author":"Hebbard","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120599_bib10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jhep.2011.04.010","article-title":"NASH animal models: are we there yet?","volume":"55","author":"Kohli","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biomaterials.2020.120599_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cotox.2019.03.001","article-title":"Human in vitro models of nonalcoholic fatty liver disease","volume":"16","author":"M\u00fcller","year":"2019","journal-title":"Current Opinion in Toxicology"},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120599_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179995","article-title":"Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis","volume":"12","author":"Prestigiacomo","year":"2017","journal-title":"PloS One"},{"issue":"20","key":"10.1016\/j.biomaterials.2020.120599_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90954","article-title":"Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis","volume":"1","author":"Feaver","year":"2016","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120599_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5009\/gnl.2012.6.2.149","article-title":"NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications","volume":"6","author":"Farrell","year":"2012","journal-title":"Gut Liver"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120599_bib15","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.biomaterials.2020.120599_bib16","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1039\/C8AN00729B","article-title":"Electrical impedance tomography for real-time and label-free cellular viability assays of 3D tumour spheroids","volume":"143","author":"Wu","year":"2018","journal-title":"Analyst"},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120599_bib17","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1039\/C8LC00067K","article-title":"A planar impedance sensor for 3D spheroids","volume":"18","author":"Curto","year":"2018","journal-title":"Lab Chip"},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120599_bib18","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1074\/jbc.M310999200","article-title":"Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen","volume":"279","author":"Han","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120599_bib19","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jhep.2008.01.026","article-title":"Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis","volume":"48","author":"Lackner","year":"2008","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120599_bib20","doi-asserted-by":"crossref","first-page":"B55","DOI":"10.1149\/2.1201802jes","article-title":"Impedance characterization of chitosan cytotoxicity to MCF-7 breast cancer cells using a multidisc indium tin oxide microelectrode array","volume":"165","author":"Park","year":"2018","journal-title":"J. Electrochem. Soc."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120599_bib21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cmet.2019.05.007","article-title":"Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids","volume":"30","author":"Ouchi","year":"2019","journal-title":"Cell Metabol."},{"key":"10.1016\/j.biomaterials.2020.120599_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.matbio.2015.01.004","article-title":"Matrix metalloproteinases in liver injury, repair and fibrosis","volume":"44\u201346","author":"Duarte","year":"2015","journal-title":"Matrix Biol."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120599_bib23","first-page":"1531","article-title":"Development and validation of an in vitro 3D model of NASH with severe fibrotic phenotype","volume":"11","author":"Mukherjee","year":"2019","journal-title":"Am J Transl Res"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120599_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jceh.2017.09.004","article-title":"Matrix metalloproteinases (MMPs) in liver diseases","volume":"7","author":"Naim","year":"2017","journal-title":"J Clin Exp Hepatol"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120599_bib25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/1319-3767.45072","article-title":"Reversal of liver fibrosis","volume":"15","author":"Ismail","year":"2009","journal-title":"Saudi J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120599_bib26","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s12020-014-0384-x","article-title":"Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients","volume":"48","author":"Pan","year":"2015","journal-title":"Endocrine"},{"issue":"8","key":"10.1016\/j.biomaterials.2020.120599_bib27","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/carcin\/bgu109","article-title":"Evidence for a role of E-cadherin in suppressing liver carcinogenesis in mice and men","volume":"35","author":"Schneider","year":"2014","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120599_bib28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.5604\/01.3001.0012.0916","article-title":"New insights about albumin and liver disease","volume":"17","author":"Carvalho","year":"2018","journal-title":"Ann. Hepatol."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120599_bib29","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1073\/pnas.1322731111","article-title":"Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis","volume":"111","author":"Nakagawa","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120599_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clinre.2014.09.008","article-title":"E-cadherin, guardian of liver physiology","volume":"39","author":"Gonzalez-Sanchez","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120599_bib31","doi-asserted-by":"crossref","first-page":"14297","DOI":"10.1038\/s41598-018-32722-6","article-title":"Human hepatic 3D spheroids as a model for steatosis and insulin resistance","volume":"8","author":"Kozyra","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120599_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212108","article-title":"Drug sensitivity prediction with high-dimensional mixture regression","volume":"14","author":"Li","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.biomaterials.2020.120599_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13036-019-0148-5","article-title":"Human three-dimensional in vitro model of hepatic zonation to predict zonal hepatotoxicity","volume":"13","author":"Ahn","year":"2019","journal-title":"J. Biol. Eng."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120599_bib34","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1038\/s41467-018-05450-8","article-title":"Interleukin-2 induces the in vitro maturation of human pluripotent stem cell-derived intestinal organoids","volume":"9","author":"Jung","year":"2018","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120599_bib35","first-page":"1118","article-title":"Development of a human cardiac organoid injury model reveals innate regenerative potential","volume":"144","author":"Voges","year":"2017","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120599_bib36","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100300","article-title":"Long-term expanding human airway organoids for disease modeling","volume":"38","author":"Sachs","year":"2019","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120599_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/jcp.27175","article-title":"Endotoxin regulates matrix genes increasing reactive oxygen species generation by intercellular communication between palmitate-treated hepatocyte and stellate cell","volume":"234","author":"Dornas","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120599_bib38","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.2353\/ajpath.2010.100166","article-title":"SCG10 expression on activation of hepatic stellate cells promotes cell motility through interference with microtubules","volume":"177","author":"Paradis","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120599_bib39","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1038\/s41598-017-07813-5","article-title":"The mechanical properties of individual cell spheroids","volume":"7","author":"Blumlein","year":"2017","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.biomaterials.2020.120599_bib40","doi-asserted-by":"crossref","first-page":"218101","DOI":"10.1103\/PhysRevLett.104.218101","article-title":"Aspiration of biological viscoelastic drops","volume":"104","author":"Guevorkian","year":"2010","journal-title":"Phys. Rev. Lett."},{"key":"10.1016\/j.biomaterials.2020.120599_bib41","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3389\/fphar.2018.00738","article-title":"Casein kinase 1delta\/epsilon inhibitor, PF670462 attenuates the fibrogenic effects of transforming growth factor-beta in pulmonary fibrosis","volume":"9","author":"Keenan","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120599_bib42","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3390\/s8021198","article-title":"Dependence of impedance of embedded single cells on cellular behaviour","volume":"8","author":"Cho","year":"2008","journal-title":"Sensors"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120599_bib43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1085\/jgp.9.2.153","article-title":"The electric resistance and capacity of blood for frequencies between 800 and 4(1\/2) million cycles","volume":"9","author":"Fricke","year":"1925","journal-title":"J. Gen. Physiol."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120599_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/nano9070923","article-title":"Unique constant phase element behavior of the electrolyte-graphene interface","volume":"9","author":"Sun","year":"2019","journal-title":"Nanomaterials"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120599_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw0463","article-title":"Vapor-printed polymer electrodes for long-term, on-demand health monitoring","volume":"5","author":"Kim","year":"2019","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120599_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10544-006-6381-y","article-title":"A SiC microdevice for the minimally invasive monitoring of ischemia in living tissues","volume":"8","author":"Gomez","year":"2006","journal-title":"Biomed. Microdevices"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120599_bib47","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1088\/0967-3334\/20\/4\/201","article-title":"The electric resistivity of human tissues (100 Hz-10 MHz): a meta-analysis of review studies","volume":"20","author":"Faes","year":"1999","journal-title":"Physiol. Meas."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120599_bib48","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1088\/0967-3334\/26\/2\/016","article-title":"Bioimpedance dispersion width as a parameter to monitor living tissues","volume":"26","author":"Ivorra","year":"2005","journal-title":"Physiol. Meas."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961220308450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961220308450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:06:29Z","timestamp":1758906389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961220308450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":48,"alternative-id":["S0142961220308450"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120599","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of non-alcoholic fatty liver disease progression in 3D liver microtissues using impedance spectroscopy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120599","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120599"}}